These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2490746)

  • 1. Quantification of the putative neurotoxin 2-amino-3-(methylamino)propanoic acid (BMAA) in cycadales: analysis of the seeds of some members of the family Cycadaceae.
    Duncan MW; Kopin IJ; Crowley JS; Jones SM; Markey SP
    J Anal Toxicol; 1989; 13(4):suppl A-G. PubMed ID: 2490746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam.
    Duncan MW; Steele JC; Kopin IJ; Markey SP
    Neurology; 1990 May; 40(5):767-72. PubMed ID: 2330104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.
    Cox PA; Banack SA; Murch SJ
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13380-3. PubMed ID: 14612559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros.
    Kisby GE; Ellison M; Spencer PS
    Neurology; 1992 Jul; 42(7):1336-40. PubMed ID: 1620343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of BMAA neurotoxicity: a critical review.
    Karamyan VT; Speth RC
    Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
    Murch SJ; Cox PA; Banack SA; Steele JC; Sacks OW
    Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cyanobacterial neurotoxin β-N-methylamino-l-alanine within shellfish in the diet of an ALS patient in Florida.
    Banack SA; Metcalf JS; Bradley WG; Cox PA
    Toxicon; 2014 Nov; 90():167-73. PubMed ID: 25123936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-MS/MS determination of the isomeric neurotoxins BMAA (beta-N-methylamino-L-alanine) and DAB (2,4-diaminobutyric acid) in cyanobacteria and seeds of Cycas revoluta and Lathyrus latifolius.
    Krüger T; Mönch B; Oppenhäuser S; Luckas B
    Toxicon; 2010; 55(2-3):547-57. PubMed ID: 19825383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam.
    Banack SA; Cox PA
    Neurology; 2003 Aug; 61(3):387-9. PubMed ID: 12913204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for non-protein amino acids in seeds of the Guam cycad, Cycas circinalis, by an improved GC-MS method.
    Oh CH; Brownson DM; Mabry TJ
    Planta Med; 1995 Feb; 61(1):66-70. PubMed ID: 7700995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
    Rao SD; Banack SA; Cox PA; Weiss JH
    Exp Neurol; 2006 Sep; 201(1):244-52. PubMed ID: 16764863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cycad neurotoxic amino acid, beta-N-methylamino-L-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells.
    Brownson DM; Mabry TJ; Leslie SW
    J Ethnopharmacol; 2002 Oct; 82(2-3):159-67. PubMed ID: 12241991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
    Bradley WG; Mash DC
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective quantitation of the neurotoxin BMAA by use of hydrophilic-interaction liquid chromatography-differential mobility spectrometry-tandem mass spectrometry (HILIC-DMS-MS/MS).
    Beach DG; Kerrin ES; Quilliam MA
    Anal Bioanal Chem; 2015 Nov; 407(28):8397-409. PubMed ID: 26396078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Previous studies underestimate BMAA concentrations in cycad flour.
    Cheng R; Banack SA
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():41-3. PubMed ID: 19929730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creating a Simian Model of Guam ALS/PDC Which Reflects Chamorro Lifetime BMAA Exposures.
    Banack SA; Cox PA
    Neurotox Res; 2018 Jan; 33(1):24-32. PubMed ID: 28478528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
    Ince PG; Codd GA
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMAA--an unusual cyanobacterial neurotoxin.
    Vyas KJ; Weiss JH
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():50-5. PubMed ID: 19929732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Collaborative Evaluation of LC-MS/MS Based Methods for BMAA Analysis: Soluble Bound BMAA Found to Be an Important Fraction.
    Faassen EJ; Antoniou MG; Beekman-Lukassen W; Blahova L; Chernova E; Christophoridis C; Combes A; Edwards C; Fastner J; Harmsen J; Hiskia A; Ilag LL; Kaloudis T; Lopicic S; Lürling M; Mazur-Marzec H; Meriluoto J; Porojan C; Viner-Mozzini Y; Zguna N
    Mar Drugs; 2016 Feb; 14(3):. PubMed ID: 26938542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the potent cyanobacterial neurotoxin β-methylamino-L-alanine (BMAA) and its analytical determination.
    Porojan C; Mitrovic SM; Yeo DC; Furey A
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2016 Oct; 33(10):1570-1586. PubMed ID: 27652898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.